These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 38053073)

  • 1. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study.
    Alami HE; Haddou I; Benaadi G; Lkhider M; Wakrim L; Allali M; Abidi O; Ghazal H; Idrissi NA; Nabih N; Naamane A; Maaroufi A; Khlil N; Hamdi S
    Pan Afr Med J; 2022; 43():86. PubMed ID: 36605985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
    Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
    Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between HbA1c and Lipid Profile Seen in Bangladeshi Type 2 Diabetes Mellitus Patients Attending BIRDEM Hospital: A Cross-Sectional Study.
    Begum A; Irfan SR; Hoque MR; Habib SH; Parvin S; Malek R; Akhter S; Sattar S; Sarkar S
    Mymensingh Med J; 2019 Jan; 28(1):91-95. PubMed ID: 30755556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
    Colhoun HM; Leiter LA; Müller-Wieland D; Cariou B; Ray KK; Tinahones FJ; Domenger C; Letierce A; Israel M; Samuel R; Del Prato S
    Cardiovasc Diabetol; 2020 Feb; 19(1):14. PubMed ID: 32035487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
    Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
    J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pattern of dyslipidemia among Somali type 2 diabetic patients: a cross-sectional study.
    Alıcı G; Genç Ö
    Eur J Med Res; 2022 Nov; 27(1):253. PubMed ID: 36404351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.
    Trautwein EA; Koppenol WP; de Jong A; Hiemstra H; Vermeer MA; Noakes M; Luscombe-Marsh ND
    Nutr Diabetes; 2018 May; 8(1):30. PubMed ID: 29795368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes.
    Le PT; Huisingh CE; Ashraf AP
    Endocr Pract; 2013; 19(6):972-9. PubMed ID: 23807519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.
    Petitti DB; Imperatore G; Palla SL; Daniels SR; Dolan LM; Kershnar AK; Marcovina S; Pettitt DJ; Pihoker C;
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):159-65. PubMed ID: 17283301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
    Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C
    Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between brachial-ankle pulse wave velocity and glycemic control of type 2 diabetes mellitus patients in Beijing community population].
    Sun KX; Liu ZK; Cao YY; Juan J; Xiang X; Yang C; Huang SP; Liu XF; Li N; Tang X; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):431-6. PubMed ID: 26080871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Lipid Profile and Its Association with Diabetes and Prediabetes in a Rural Bangladeshi Population.
    Bhowmik B; Siddiquee T; Mujumder A; Afsana F; Ahmed T; Mdala IA; do V Moreira NC; Khan AKA; Hussain A; Holmboe-Ottesen G; Omsland TK
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
    Rosenson RS; Carlson DM; Kelly MT; Setze CM; Hirshberg B; Stolzenbach JC; Williams LA
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):47-57. PubMed ID: 21174145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.